Lipopolysaccharide induces a synergistic uptake of tritiated thymidine in peripheral blood lymphocytes (PBL) when cultured with phytohemagglutinin or concanavalin A as compared to PBL incubated only with phytohemagglutinin or concanavalin A. In this study we investigated which subpopulation(s) of PBL is involved in this synergistic increase in deoxyribonucleic acid synthesis. Separation of PBL into sheep erythrocyte rosette-forming cells (T cells) and non-rosetteforming cells (B cells) showed that the T cells were responsible for the increased uptake of radiolabel. PBL and T cells had similar dose-response profiles and kinetic patterns. Paralleling this augmented tritiated thymidine uptake was an increase in the number of cells undergoing blast transformation. Delayed-addition experiments showed that the two mitogens must be added within 12 h of each other for maximal augmentation to occur. Finally, preincubation of T cells with lipopolysaccharide had no demonstrable effect on the amount of concanavalin A uptake by these cells. This model may provide unique information about the activation of human peripheral blood T cells compared to activation of these cells by one mitogen.
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Lipopolysaccharide (LPS) derived from gramnegative bacteria is a potent mitogen for bone marrow-derived (B) lymphocytes in mice and rats (1, 8, 14) . However, LPS has no such effect on human peripheral blood B cells (14, 17) unless these cells are cultured for long periods of time (7 to 9 days) with prescreened lots of fresh human serum (10) . For maximal B-cell activation by LPS, thymus-derived (T) cells are also required (10 LPS has been shown to influence the activation of murine T lymphocytes. Ozato et al. (13) showed that ConA-induced activation of CBA mouse thymocytes could be augmented by a single dose of LPS. Forbes et al. (7) showed that LPS and ConA synergistically activated thymocytes from C57BL/6 mice. However, neither PHA nor PWM was active with LPS. Recently, Dumont (6) reported that LPS-augmented ConA induced activation of murine thymocytes from mice of both low-LPS-responder C3H/Hej and high-LPS-responder CBA mice.
Nakano et al. (11) reported that LPS-treated donor bone marrow or thymus cells transferred to a heavily irradiated recipient could enhance anti-SRBC antibody responses as long as both cell types were transferred together and either cell type could be treated with LPS. Armerding and Katz (2) showed that for LPS to augment secondary 2,4-dinitrophenol-KLH antibody responses, helper T cells were required. These authors speculated that the effect of LPS on antibody formation depended on whether or not the B cells were responding to a T-independent or T-dependent antigen. In the case of T-independent antigens, LPS enhanced B cells directly. When T-dependent antigens were examined, LPS exerted its effect on T cells. Newburger et al. (12) reported data showing that LPS augmented immunoglobulins E and G antibody responses to 2,4-dinitrophenol-protein conjugates in mice by augmenting the response of carrierspecific helper T cells.
We hypothesize that LPS augments ConA-or PHA-induced DNA synthesis in human peripheral blood T lymphocytes by at least two possible mechanisms. First, LPS may be conferring on a subpopulation of T cells unresponsiveness to PHA, ConA, or PWM or the ability to respond to the mitogen or to LPS itself. Data in Table 2 indicate that, proportionately, more cells are (Table 4) . We do know, however, that a second signal delivered by LPS must be received by the responding T lymphocytes within 12 h of Con A addition for maximal effect of LPS (Table 3) . Studies are now under way to fractionate human T-lymphocyte subpopulations to determine the actual mechanism by which LPS augments PHA-, ConA-, and PWMinduced activation of these cells.
Clinically, this model may provide useful information about the status of cellular immunity which is not available by activation of human PBL with PHA or ConA alone. For example, a defective response to ConA and LPS, in comparison to ConA alone, might indicate a real or functional absence of a particular subpopulation of T cells activated by ConA and LPS. The relevance of such a finding to particular disease states remains to be established.
